SHAWN AGENBROAD-ELANDER: Open Payments
NPI 1164655171 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,974 in 94 payments from 23 companies in 2025. Trend: 2023 $1,475 · 2024 $1,631 · 2025 $1,974
Food & beverage: $1,927Education: $47
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 17 | $384 |
| Novo Nordisk Inc | 13 | $230 |
| ABBVIE INC. | 19 | $189 |
| Shockwave Medical, Inc | 1 | $176 |
| Otsuka America Pharmaceutical, Inc. | 5 | $167 |
| AstraZeneca Pharmaceuticals LP | 4 | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $106 |
| Supernus Pharmaceuticals, Inc. | 3 | $65 |
| Abbott Laboratories | 3 | $64 |
| Corcept Therapeutics | 4 | $64 |
Products named: JARDIANCE, VRAYLAR, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, BREZTRI, MOUNJARO, KISUNLA, Ozempic, REXULTI.
Industry payments across TX — which companies pay providers there.
